Skip to main content

Table 1 Demographical and clinical data of participants

From: Potential ocular indicators to distinguish posterior cortical atrophy and typical Alzheimer’s disease: a cross-section study using optical coherence tomography angiography

Characteristics

HC

AD

PCA

P-value

(n = 30)

(n = 19)

(n = 12)

Age (years)

61.93 ± 5.11

62.53 ± 6.96

62.42 ± 5.73

0.934

Gender (M/F)

9/21

10/9

7/5

0.139

Education (years)

9.00 ± 3.95

8.53 ± 4.16

9.83 ± 4.45

0.691

MMSE

27.40 ± 1.85

17.32 ± 6.56*

12.92 ± 4.54*

 < 0.001

 Memorya

5.10 ± 0.96

3.00 ± 1.37*

3.08 ± 1.00*

 < 0.001

 Visuospatial abilityb

1.90 ± 0.31

1.16 ± 0.83*

0.17 ± 0.39*

 < 0.001

MoCA

23.73 ± 3.33

13.21 ± 5.79*

8.75 ± 4.48*#

 < 0.001

CDR

0

1.79 ± 0.86*

2.00 ± 0.60*

 < 0.001

SPH (D)

-0.15 ± 1.11

-0.42 ± 1.40

-0.41 ± 1.21

0.577

CYL (D)

0.86 ± 0.63

0.61 ± 0.56

0.89 ± 0.95

0.178

AX (degree)

123.04 ± 73.10

122.35 ± 70.87

131.75 ± 68.49

0.896

IOP (mmHg)

14.65 ± 2.61

13.51 ± 3.03

13.27 ± 3.10

0.053

  1. Abbreviations: HC Healthy control, AD Alzheimer’s disease, PCA Posterior cortical atrophy, MMSE Mini-Mental State Examination, MoCA Montreal Cognitive Assessment, CDR Clinical dementia rating scale, SPH Sphere, CYL cylinder, AX Axial, IOP Intra-ocular pressure. Assessment values are mean ± standard deviation (SD), or n. The bold values indicate statistical significance
  2. * p < 0.001: AD, PCA vs HC, by post hoc test
  3. # p < 0.05: AD vs PCA, by post hoc test
  4. a Memory refers to Registration and Recall parts in MMSE, maximum score for 6
  5. b Visuospatial ability refers to sentence writing and picture copying parts in MMSE, maximum score for 2